Latest News of GLYC
Zealand Pharma Gets FDA Complete Response Letter for Hypoglycemia New Drug Application
By MarketWatch |
1 month ago
Zealand Pharma received a complete response letter from the FDA regarding its new drug application for dasiglucagon to treat hypoglycemia in pediatric patients with congenital hyperinsulinism. The let...
Senior VP & Chief Medical Officer of GlycoMimetics Edwin Rock Buys 81% More Shares
By Yahoo! Finance |
4 months ago
GlycoMimetics' Senior VP & Chief Medical Officer bought $79k worth of stock, boosting their shareholding by 81%. Other insiders also purchased shares, indicating optimism. However, insider ownership i...